Data / Form D filings / Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc.: Form D filings
Vascular Pharmaceuticals, Inc., a biotechnology company in Chapel Hill, NC, filed 6 Form D notices with the SEC between 2012 and 2016. The latest, on January 6, 2016, reports $3 million sold of a $3 million offering to 6 investors.
Find out what Vascular Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 510 MEADOWMONT VILLAGE CIRCLE, SUITE 283, Chapel Hill, NC, 27517
- Phone
- (919) 966-4735
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1557160
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 6, 2016 | New notice | $3,000,000 | $3,000,000 | $0 | 6 | Dec 23, 2015 | sec.gov |
| Feb 20, 2015 | Amendment | $25,121,488 | $15,121,488 | $10,000,000 | 6 | Sep 10, 2012 | sec.gov |
| Jan 21, 2015 | Amendment | $19,121,487 | $13,121,487 | $6,000,000 | 4 | Sep 10, 2012 | sec.gov |
| Nov 19, 2013 | Amendment | $16,008,333 | $9,008,333 | $7,000,000 | 3 | Sep 10, 2012 | sec.gov |
| Aug 23, 2013 | New notice | $1,500,000 | $1,000,000 | $500,000 | 3 | Aug 15, 2013 | sec.gov |
| Sep 24, 2012 | New notice | $16,008,333 | $6,008,329 | $10,000,004 | 3 | Sep 10, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Benjamin Rovinski | Director | |
| Elizabeth Stoner | Director | |
| David Clemmons | Director | |
| Richard Shea | Executive Officer, Director | |
| Bonnie Layman | Executive Officer | |
| Richard Kent | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jan 4, 2016 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vascular Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.